Mr Haney Youssef, Consultant Colorectal and General Surgeon
Mr Haney Youssef
Consultant Colorectal and General Surgeon
Mr Haney Youssef MB ChB PGCert MedEd MScR FRCSEd (GenSurg)
Consultant Colorectal and General Surgeon
Mr Haney Youssef
Consultant Colorectal and General Surgeon MB ChB PGCert MedEd MScR FRCSEd (GenSurg)
Mr Youssef is a Consultant Colorectal and General Surgeon
Areas of expertise
- Colorectal (bowel) cancer
- Appendix cancer
- Inflammatory bowel disease
- Haemorrhoids (piles)
- Gallstones
Make an appointment
Address
-
The Harborne Hospital, part of HCA Healthcare UK
Mindelsohn Way, Birmingham, B15 2FQ
Heart Of England NHS Foundation Trust
Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, West Midlands, B9 5ST
About Mr Haney Youssef
GMC number: 4401368
Year qualified: 1997
Place of primary qualification: University of Birmingham
Mr Haney Youssef is a distinguished colorectal and general surgeon affiliated with The Harborne Hospital, part of HCA Healthcare UK. His primary focus is on various bowel and abdominal conditions, with a particular interest in bowel, appendix, and peritoneal cancer. Notably, he established the Birmingham Peritoneal Malignancy Unit, which is recognised as one of the three specialist centres in England.
Mr Youssef graduated from the University of Birmingham in 1997. He underwent extensive training in the West Midlands and pursued specialised fellowship training at Basingstoke, the Washington Cancer Institute, and University Hospital Leuven.
Currently, Mr Youssef serves as a consultant surgeon at University Hospitals Birmingham NHS Foundation Trust, which includes Queen Elizabeth Hospital, Heartlands Hospital, Good Hope Hospital, and Solihull Hospital. He has also held the position of Clinical Lead for the Colorectal and General Surgical service.
A practicing Christian, Mr Youssef attends the Coptic Orthodox Church. In his leisure time, he enjoys swimming, playing squash, walking, and appreciating music.
Mr Youssef's dedication to his field and his patients is evident through his extensive training, leadership roles, and the establishment of a specialist unit for peritoneal malignancy.
Areas of expertise
- Anal fissure
- Anal fistula
- Appendix cancer
- Bowel cancer surgery - keyhole and open - colon and recal cancer
- Bowel operations for diverticular disease
- Colonoscopy
- Colorectal (bowel) cancer
- Cytoreductive surgery
- Diverticular disease
- Excision of skin lumps and bumps (lipomas and cysts)
- Gallstones
- Haemorrhoidectomy
- Haemorrhoids/piles surgery - including THD, RAFAELO, banding of piles
- Heated intraperitoneal chemotherapy
- Hernia surgery - inguinal, femoral (groin) and umbilical (belly button), epigastric and abdominal wall
- Inflammatory bowel disease
- Laparoscopic cholecystectomy (keyhole gallbladder removal for gallstones)
- Peritoneal malignancy surgery
- Peritoneal mesothelioma
- Pilonidal excision and primary closure
- Pilonidal sinuses
- Skin lesions
Professional memberships
Articles by Mr Haney Youssef
Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Analysis of 1138 patients from the uk and ireland colorectal peritoneal metastases registry
Peritoneal malignancy
Low preoperative serum albumin levels are associated with impaired outcome after cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancies
The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden
The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with a hypermutant, hypermethylated state
Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video?conference meeting
Predicting the difficult laparoscopic cholecystectomy
Meta?analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
Preoperative and postoperative n-terminal pro B-type natriuretic peptide levels predict cardiac morbidity and mortality in patients undergoing colorectal cancer resection
1103- Cytoreductive surgery and heated intra-peritoneal chemotherapy, how do cure rates differ between isolated and disseminated colorectal peritoneal metastasis?
Malnutrition is associated with adverse postoperative outcome in patients undergoing elective colorectal cancer resections
